JUL 29, 2015 01:55 PM PDT

Hundred-Cell Epigenomic Analysis Pumps Up Personalized Medicine

Personalized medicine could get a big boost from a new technique that is said to reduce the number of cells needed for epigenomic analysis from millions to just 100, according to an article written by Bevin Fletcher, associate editor, in Bioscience Technology. Fletcher explains that epigenome investigation requires DNA interaction mapping with a certain protein in the whole genome, enabling physicians to obtain a fuller picture of the state of the patient and develop a personalized treatment strategy. Because the procedure used to take about 10 million cells for a single test to study in vivo genome-wide protein-DNA interactions and chromatin modifications, this kind of analysis was impractical (http://www.biosciencetechnology.com/articles/2015/07/new-technique-allows-epigenomic-analysis-just-100-cells?et_cid=4699918&et_rid=45505806&type=cta).
Researchers say that they have developed a new epigenomics technique that can make personalized medicine a reality.
Now a new technology that improves the efficiency of epigenomic studies is described in a Nature Methods journal article by Chang Lu and Zhenning Cao of Virginia Tech and Kai Tan, Changya Chen and Bing He of the University of Iowa. The National Institutes of Health funded the research, after a seed grant from Virginia Tech's Institute for Critical Technology and Applied Science (http://scifeeds.com/news/technology-helps-personalized-medicine-enabling-epigenomic-analysis-with-a-mere-100-cells/).

In the laboratory Chang Lu, professor of chemical engineering at Virginia Tech, and his students designed a small microfluidic device with micrometer features to examine cells at a molecular level. Microfluidic oscillatory washing based chromatin immunoprecipitation (MOWChIP-Seq) was the result of a collaboration between Profs. Lu and Tan. Prof. Tan is a systems biologist and associate professor of internal medicine at the University of Iowa. The new technology assesses epigenome interactions in 90 minutes as compared to the conventional ChIP assays that had required several hours and much larger samples.

According to Prof. Lu's comments in a press release from Virginia Tech, which filed a U.S. utility patent on the technology on behalf of Prof. Lu, "The use of a packed bed of beads for ChIP allowed us to collect the chromatin fragments with a very high efficiency. At the same time, effective washing for removing undesired molecules and debris guarantees the purity of the collected molecules. These two factors constitute a successful strategy for epigenomic analysis with extremely high sensitivity."

Prof. Lu adds that the research team's next planned project is to use the new technology to study changes in the epigenome associated with cancer and inflammation. He concludes, Our technology paves the way for studies of epigenomes with extremely low number of cells from animals and from patients."
About the Author
  • Ilene Schneider is the owner of Schneider the Writer, a firm that provides communications for health care, high technology and service enterprises. Her specialties include public relations, media relations, advertising, journalistic writing, editing, grant writing and corporate creativity consulting services. Prior to starting her own business in 1985, Ilene was editor of the Cleveland edition of TV Guide, associate editor of School Product News (Penton Publishing) and senior public relations representative at Beckman Instruments, Inc. She was profiled in a book, How to Open and Operate a Home-Based Writing Business and listed in Who's Who of American Women, Who's Who in Advertising and Who's Who in Media and Communications. She was the recipient of the Women in Communications, Inc. Clarion Award in advertising. A graduate of the University of Pennsylvania, Ilene and her family have lived in Irvine, California, since 1978.
You May Also Like
DEC 06, 2019
Drug Discovery & Development
DEC 06, 2019
AI Exponentially Accelerates Drug Development
Research and development for new drugs is both an expensive and lengthy process, often lasting years, if not decades. With the development of artificial in...
DEC 06, 2019
Genetics & Genomics
DEC 06, 2019
Membrane-less Organelle Found to Play a Role in Preventing Cancer
In recent years, scientists have found that a phenomenon called phase separation plays a critical role in the functions of cells....
DEC 06, 2019
Neuroscience
DEC 06, 2019
Alcohol Consumption Linked to Epigenetic Changes in Brain Memory System
For a recovering alcoholic, walking past a familiar bar or attending social events are often challenging situations. In the past, stimuli such as the smell, sight, and sounds of a bar become...
DEC 06, 2019
Clinical & Molecular DX
DEC 06, 2019
Looking into the eyes of MS patients for personalized therapies
Blurred or double vision, and in extreme cases, complete vision loss are amongst the earliest symptoms of multiple sclerosis (MS). In this devastating dise...
DEC 06, 2019
Genetics & Genomics
DEC 06, 2019
Understanding How Loose RNA Molecules Help Rejuvenate Skin
This work may help develop new treatments for skin that is aging or damaged by wounds or burns....
DEC 06, 2019
Genetics & Genomics
DEC 06, 2019
An Epigenetic Switch Changes Warrior Ants Into Foragers
Researchers were able to change the behavior of a type of carpenter ant, and now they know the biological basis for the change....
Loading Comments...